GNH USA

Europe — EMA

Moxamar (Moxonidine)

GNH USA supplies Moxamar (Moxonidine), an imidazoline receptor agonist indicated for hypertension management. Request a quote for reliable global supply.

Moxonidine

Request sourcing

1
Pack/s

What is Moxonidine?

Moxonidine, the active ingredient in Moxamar, is an imidazoline receptor agonist presented as an oral tablet for oral use. It treats hypertension in adult patients. GNH USA supplies Moxamar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Moxonidine used for?

Moxonidine is used to manage elevated blood pressure within the cardiovascular disease pathway.

Hypertension: reduces elevated blood pressure in patients with primary hypertension.

What are the side effects of Moxonidine?

Moxonidine may cause a range of adverse reactions.

Common Side Effects: - Dry mouth: sensation of oral dryness. - Fatigue: feeling of tiredness or lack of energy. - Dizziness: light‑headed feeling, especially when standing. - Headache: mild to moderate head pain. - Nausea: feeling of queasiness. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe hypotension: markedly low blood pressure requiring medical attention. - Bradycardia: unusually slow heart rate. - Allergic reactions: rash, itching, swelling, or difficulty breathing. - Liver enzyme elevation: abnormal liver function tests. - Arrhythmia: irregular heart rhythm. - Skin disorders: severe rash or Stevens‑Johnson syndrome.

What precautions apply to Moxonidine?

Before initiating therapy, consider the following safety measures.

Monitor blood pressure: ensure adequate control and avoid excessive drops. Assess renal function: adjust use in patients with impaired kidneys. Review hepatic function: caution in liver disease. Use caution in diabetes: may affect glucose control. Avoid abrupt discontinuation: taper to prevent rebound hypertension. Store at ambient temperature: keep in the original pack, protect from moisture.

What does Moxonidine interact with?

Moxonidine can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Combined central antihypertensives (e.g., clonidine, methyldopa): risk of additive hypotension. - Potent antihypertensive combinations (e.g., ACE inhibitors with diuretics): may cause excessive blood pressure lowering.

Moderate Interactions (Monitor Closely): - NSAIDs: may diminish antihypertensive effect. - Lithium: increased risk of lithium toxicity. - Beta‑blockers: additive heart rate reduction. - Diuretics: enhanced diuretic‑induced electrolyte changes. - Alcohol: may potentiate hypotensive effect.

Frequently asked questions

What is Moxamar used for?+
Moxamar contains the active ingredient moxonidine and is used to lower high blood pressure in adults with primary hypertension. It works by reducing sympathetic nervous system activity, helping to achieve better blood pressure control.
How does moxonidine work?+
Moxonidine selectively activates imidazoline I1 receptors in the brainstem, which diminishes sympathetic outflow. This leads to reduced peripheral vascular resistance and a subsequent decrease in arterial blood pressure.
What is the usual dose of Moxamar?+
The appropriate dose of Moxamar is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and other factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.
Is Moxamar safe during pregnancy or breastfeeding?+
The safety of moxonidine in pregnancy and lactation has not been established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.
How do I order Moxamar from GNH USA?+
To order Moxamar, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.
How does Moxamar compare with other antihypertensive drugs?+
Moxamar belongs to the imidazoline receptor agonist class, which lowers blood pressure by reducing sympathetic activity. Unlike ACE inhibitors or beta‑blockers, it targets central pathways, offering an alternative mechanism that may be useful when patients experience side effects or inadequate control with other agents.
What are the storage and handling requirements for Moxamar?+
Moxamar should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight to maintain its stability and potency.
How is Moxamar administered?+
Moxamar is taken orally, usually with or without food, as directed by the prescriber. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.
What are the most serious risks associated with Moxamar?+
Serious risks include severe hypotension, bradycardia, allergic reactions such as rash or swelling, and rare liver enzyme elevations. Patients should seek immediate medical attention if they experience symptoms like fainting, rapid heartbeat, difficulty breathing, or unusual skin changes.
Who should not use Moxamar?+
Moxamar is contraindicated in patients with known hypersensitivity to moxonidine or any excipients in the formulation. Caution is advised for individuals with severe renal or hepatic impairment, and it should be avoided in patients taking other central antihypertensive agents without medical supervision.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Moxonidine
Route
Oral Use
Manufacturer
Teva Pharma B.V.
Origin
EU

Related products

Cynt

Cynt

Moxonidine

Viatris Hrvatska D.O.O.
EU
Cynt

Cynt

Moxonidine

Viatris Healthcare Limited
EU
Cynt

Cynt

Moxonidine

Viatris Healthcare Limited
EU
Cynt

Cynt

Moxonidine

Biomin, A.S.
EU